HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

methylswertianin

an anti-diabetic agent; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - Xanthones: 211
        methylswertianin: 1

Experts

1.	Bai, X: 1 article (06/2010)
2.	Chen, J-C: 1 article (06/2010)
3.	Chen, X-H: 1 article (06/2010)
4.	Fang, J-B: 1 article (06/2010)
5.	Liu, S-H: 1 article (06/2010)
6.	Tian, L-Y: 1 article (06/2010)

Related Diseases

1.

Insulin Resistance

06/01/2010 - "In conclusion, these result indicated that methylswertianin and bellidifolin could be useful for treating type-2 diabetes, likely via the improvement of insulin resistance (IR)."
06/01/2010 - "Methylswertianin and bellidifolin appeared to improve insulin resistance by enhancing insulin signaling. "
06/01/2010 - "In this study, we continued to investigate the hypoglycemic activity of Swertia punicea Helmsl., the hypoglycemic and hypolipidemic effects of methylswertianin and bellidifolin from the active ethyl acetate (EtOAc) fraction, and the potential mechanism(s) underlying the improvement of insulin resistance. "

Related Drugs and Biologics

1.	Hypoglycemic Agents (Hypoglycemics)
2.	bellidifolin
3.	ethyl acetate
4.	Insulin (Novolin)